lunsumio
roche registration gmbh - mosunetuzumab - limfom, folicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
sodium lactat ringer 1,55 g+3,0 g+0,15 g+0,1 g soluţie perfuzabilă
cisen pharmaceutical co., ltd. - combinaţie - soluţie perfuzabilă - 1,55 g+3,0 g+0,15 g+0,1 g
sodium lactat ringer 1,55 g+3,0 g+0,15 g+0,1 g soluţie perfuzabilă
cisen pharmaceutical co., ltd. - combinaţie - soluţie perfuzabilă - 1,55 g+3,0 g+0,15 g+0,1 g
glucoza solutie perfuzabila 10%
anhui double-crane pharmaceutical co., ltd - glucoza - solutie perfuzabila - 10%
glucoza solutie perfuzabila 5%
anhui double-crane pharmaceutical co., ltd - glucoza - solutie perfuzabila - 5%
glucoza solutie perfuzabila 5%
anhui double-crane pharmaceutical co., ltd - glucoza - solutie perfuzabila - 5%
glucoza solutie perfuzabila 5%
anhui double-crane pharmaceutical co., ltd - glucoza - solutie perfuzabila - 5%
glucoza solutie perfuzabila 5%
anhui double-crane pharmaceutical co., ltd - glucoza - solutie perfuzabila - 5%
glucoza solutie perfuzabila 5%
anhui double-crane pharmaceutical co., ltd - glucoza - solutie perfuzabila - 5%
glucoza solutie perfuzabila 10%
anhui double-crane pharmaceutical co., ltd - glucoza - solutie perfuzabila - 10%